Fighting Disparities & the Leading Causes of Death in Women

Thank you for attending this CME activity!

Please click here to complete the activity evaluation. Certificates will be disseminated approximately 2 to 4 weeks after the activity.

Please click on the links below to access slides from the presentations.

May 3, 2013: CME Agenda

8:00 AM Registration and Continental Breakfast
8:30 AM Welcome and Overview—Michael Kastan, MD, PhD; Executive Director, the Duke Cancer Institute 
8:40 AM Stroke Epidemiology and Risk Factors in Women—Larry B. Goldstein, MD
9:00 AM Stroke Prevention in Women—Cheryl Bushnell, MD
9:20 AM Carotid Intervention for Stroke Prevention in Women – Cynthia Shortell, MD
9:40 AM Acute Stroke and Outcomes in Women—Louise McCullough, MD
10:00 AM Pregnancy Complications: Predicting the Future Risk for Stroke, Cardiovascular Disease and Metabolic Syndrome—Amy Murtha, MD
10:20 AM Questions for Stroke Panel
10:50 AM Break
11:10 AM Evidence-based Risk Factor Reduction and Prevention of Cardiovascular Disease in Women—Rowena Dolor, MD 
11:30 AM Chest Pain in Women: Wise Women Study—Noel Bairey-Merz, MD  
11:50 AM Managing Metabolic Syndrome in Women—Diana McNeill, MD
12:10 PM Cardio-Oncology: Imaging and Monitoring of Women Cancer Survivors—Pamela Douglas, MD  
12:40 PM Questions for Cardiovascular Panel
1:10 PM Lunch
1:30 PM Keynote Speaker: Handel E. Reynolds, MD
Author of The Big Squeeze: A Social & Political History of the Controversial Mammogram
2:10 PM The Importance of Survivorship Care—Quality and Pathways—Steve Patierno, PhD  
2:30 PM Treatment of Breast Cancer with Exercise—Lee Jones, PhD
2:50 PM Estrogen Depletion—Its Importance in Breast Cancer and Management of Side Effects—Kimberly Blackwell, MD
3:10 PM Screening for Breast Cancer in the Breast Cancer Survivor and High-Risk Patient—Lisa Tolnitch, MD 
3:30 PM Hereditary Cancer Syndromes that You Should Know About—P. Kelly Marcom, MD
3:50 PM Prospects for Early Detection and Prevention of Ovarian Cancer—Andrew Berchuck, MD
4:10 PM Questions for Oncology Panel
4:45 PM Course Evaluation/Adjournment